期刊
JOURNAL OF THE AMERICAN HEART ASSOCIATION
卷 6, 期 4, 页码 -出版社
WILEY
DOI: 10.1161/JAHA.116.004653
关键词
anthracycline; cancer; cardiotoxicity; microRNA; pediatric
资金
- National Institutes of Health [UL1TR001 105]
- NIH [T32HL007360-35, R0 1, R0 1 HL 102478]
- Conquer Cancer & Strike3 Foundations under American Society of Clinical Oncology (ASCO)
- Children's Cancer Fund of Dallas
Background-Biomarkers for early detection of anthracycline (AC)-induced cardiotoxicity may allow cardioprotective intervention before irreversible damage. Circulating microRNAs (miRNAs) are promising biomarkers of cardiovascular disease, however, have not been studied in the setting of AC-induced cardiotoxicity. This study aimed to identify AC-induced alterations in plasma miRNA expression in children and correlate expression with markers of cardiac injury. Methods and Results-Candidate plasma profiling of 24 miRNAs was performed in 33 children before and after a cycle of AC (n= 24) or noncardiotoxic chemotherapy (n= 9). Relative miRNA changes between the pre- and postcycle time points (6, 12, and 24 hours) were determined within each treatment group and compared across groups. Plasma miRNA expression patterns were further explored with respect to AC dose and high-sensitivity troponin T. Greater chemotherapy-induced dysregulation was observed in this panel of candidate, cardiac-related plasma miRNAs in patients receiving anthracyclines compared with those receiving noncardiotoxic chemotherapy (24-hour MANOVA; P=0.024). Specifically, plasma miRs-29b and -499 were upregulated 6 to 24 hours post-AC, and their postchemotherapy expression significantly correlated with AC dose. Patients with acute cardiomyocyte injury (high-sensitivity troponin T increase >= 5 ng/L from baseline) demonstrated higher expression of miR-29b and miR-499 post-AC compared with those without. Conclusions-In this pilot study, cardiac-related plasma miRNAs are dysregulated following ACs. Plasma miR-29b and -499 are acutely elevated post-AC, with dose response relationships observed with anthracycline dose and markers of cardiac injury. Further evaluation of miRNAs may provide mechanistic insight into AC-induced cardiotoxicity and yield biomarkers to facilitate earlier intervention to mitigate cardiotoxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据